Raily Aesthetic Medicine International Holdings Limited (HK:2135) has released an update.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Raily Aesthetic Medicine International Holdings Limited has issued a profit warning, expecting a revenue of RMB117 million and a loss of RMB2 million for the first half of 2024, consistent with the previous year’s loss. This continued loss is primarily due to increased investments in research and development and higher share option expenses. The company advises shareholders and potential investors to exercise caution when dealing in its shares.
For further insights into HK:2135 stock, check out TipRanks’ Stock Analysis page.